Get startedLog in
    Picture of Natco Pharma logo

    NATCOPHARM — Natco Pharma Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapContrarian
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Natco Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line5,7962,0228,61916,73522,914
    Depreciation
    Non-Cash Items-548-187-618-530-2,575
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-3,429-2,796-1,148-5,957-5,723
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities2,9884658,49112,11616,968
    Capital Expenditures-2,546-2,328-2,056-3,587-5,116
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items1,5132,275-2,715-6,740-9,029
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities-1,033-53-4,771-10,327-14,145
    Financing Cash Flow Items-223-188-142-181-176
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-1,857348-3,630-2,469-2,107
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash60853208-615496